Descending control of pain
Section snippets
General introduction: scope and aims of review
Some 30-odd years ago, the concept was evoked that nociceptive information impinging upon the dorsal horn (DH) of the spinal cord from the skin, viscera and other tissues, is not automatically transferred to higher centres (Melzack and Wall, 1965). Rather, in accordance with now familiar “gate” terminology, processes integrated at the terminals of nocisponsive (pain-sensitive) primary afferent fibres (PAFs), and at the projection neurones (PNs) which they target, profoundly modify nociceptive
Neuronal circuitry in the DH
For an understanding of the operation of descending pathways, it is essential to briefly consider their relationship to PAFs and other neuronal elements in the DH (Fig. 1). There is a vast literature devoted to synaptic processing of nociceptive input in the DH and the reader is referred to several more thorough and technical accounts for additional information Besson and Chaouch, 1987, Willis, 1988, Willis and Coggeshall, 1991, Levine et al., 1993, Todd and Spike, 1993, Coggeshall and Carlton,
Common sites of origin for mechanisms of descending inhibition and facilitation
There is no absolute anatomical separation between structures involved in the initiation of mechanisms of DI as compared to DF (Table 1). Common loci in both the rostroventromedial medulla (RVM) and NTS, for example, give rise to descending pathways engendering DI or DF, albeit via contrasting mechanisms. Fields et al., 1991, Watkins et al., 1994, Wiertelak et al., 1997, Fields and Basbaum, 1999, McNally, 1999, Urban et al., 1999a, Urban et al., 1999b, Urban et al., 1999c, Nuseir and Proudfit,
Interplay of descending inhibition and facilitation in the signalling of nociceptive information
In general, for pain reflecting excessive stimulation of specialised nociceptors, there is an adaptive relationship between the signalling of noxious stimuli and actual or impending tissue damage, corresponding to the crucial warning function of pain. However, the “input–output” equation for nociceptive transmission is far from invariant and may be weighted either in favour of, or against, its passage by an abundance of mechanisms including DI and DF Besson and Chaouch, 1987, Willis and
Multiple classes of adrenoceptor
Three major classes of AR can be recognised: α1-, α2- and β-ARs Ruffolo et al., 1993, Bylund et al., 1994, Hieble et al., 1995, Kukkonen et al., 2001, Piascik and Perez, 2001. Three subtypes of the former have been cloned: α1A, α1B and α1D, which are collectively characterised by their positive coupling via Gq/11 to voltage-gated Ca2+-channels and phospholipase C (PLC), activation of which mobilises intracellular pools of calcium. (The pharmacologically-defined α1C-AR has been abandoned)
Multiple classes of dopamine receptor
Dopamine (DA) receptors are classified into two families: D2-like, incorporating D2 and closely-related D3 and D4 receptors, and D1-like which includes D1 and closely-related D5 receptors Missale et al., 1998, Vallone et al., 2000. Stimulation of D2, D3 and D4 receptors leads, via Gi/o, to the inhibition of AC. Activation of D2 receptors also suppresses and potentiates Ca2+- and K+-currents, respectively, although such actions have proven difficult to detect for their D3 and D4 counterparts.
Origins and projection patterns to the DH
Although a small population of 5-HT-immunoreactive cell bodies has been identified ventral to the central canal in primates (LaMotte, 1988), virtually the entire serotonergic innervation of the spinal cord in these and other species is derived from supraspinal sources. In this regard, a modest proportion of serotonergic neurones from the dorsal raphe nucleus—which predominantly innervates the thalamus, dorsal hippocampus, striatum, cerebral cortex-sends collaterals to the spinal cord and the
Multiple receptors and origins of descending histaminergic pathways
Histamine exerts its actions via four classes of receptor. Of these, H1, H2 and H3 receptors are found in the CNS, and the latter functions both post-synaptically to histaminergic neurones and as an autoreceptor on their terminals Hough, 1988, Hough, 2001. Both H1 receptors (which couple positively to PLC and PhospolipaseA2) as well as H2 receptors (which couple positively to AC) are excitatory. H3 receptors (which are negatively coupled to AC and Ca2+-currents) are inhibitory, in line with
Multiple receptors and origins of cholinergic neurones in the dorsal horn
Cholinergic mechanisms for the modulation of nociception are particularly intriguing (Table 2) inasmuch as ACh may be involved: (1) in the activation of non-cholinergic descending pathways mediating DI; (2) in the mediation of DI following its own release from descending pathways and (3) in the induction of antinociception following release from ININs in the DH. Further, ACh modulates nociception by a complex pattern of effects mediated via multiple classes of muscarinic and nicotinic receptor
Substance P
A familiar feature of the DH is the massive provision of SP (and neurokinin (NK) A)-containing, fine calibre PAFs to superficial laminae of the DH which, via activation of NK1- and, possibly, NK2- and NK3-receptors play an important role in nociceptive transmission Cao et al., 1995, Seguin et al., 1995, Mantyh et al., 1995, DeFelipe et al., 1998, Millan, 1999, Yaksh, 1999a, Laird et al., 2000, Martinez-Caro and Laird, 2000, Ribeiro-da-silva and Hökfelt, 2000, Kamp et al., 2001, Todd et al., 2000
Generation of cannabinoids: actions at CB1 receptors
Of the two classes of cannabinoid receptor to date characterized, CB1 and CB2, only the former appears to be localized in the CNS (Pertwee, 1997). Although there is increasing evidence for promiscuous (pleiotropic) coupling of CB1 receptors via various classes of G-protein to intracellular transduction mechanisms Pertwee, 1997, Pertwee, 2001, Abadji et al., 1999, Ameri, 1999 they are well-established to negatively couple via Gi/o to AC and to enhance and suppress K+- and Ca2+-currents,
General considerations
In the therapeutic exploitation of descending controls for improved pain relief, the ultimate objective would be to develop an orally-active formulation of a drug with the following characteristics: (1) effective in all patients against inflammatory and/or neuropathic pain of disparate pathologies; (2) active over a well-defined dose-range; (3) selectively suppressing nociceptive as compared to non-nociceptive input; (4) with an appropriate duration of action; (5) devoid of problems of
General discussion
In concluding the present review, it is instructive to recall several major themes which are likely to inform future research into the physiological significance and therapeutic relevance of descending controls of nociceptive processing.
First, it is critical to establish patterns of neuronal connections both in the DH and in structures from which descending controls originate, in particular as regards the transmitters and multiple classes of receptor via which individual classes of neurone
Concluding comments
The proliferation of potential analgesic drug targets for the therapeutic manipulation of descending controls is testimony to the intensive and highly-successful research programme of the past decades. In parallel, great efforts have been invested in the characterization of peripheral and central mechanisms involved in the induction of nociception. Further, there is an increasing awareness of the importance of the cognitive–affective component of pain (appreciation, tolerance and coping).
Acknowledgments
The author would like to thank M. Soubeyran, J.-M. Rivet, A. Gobert, A. Dekeyne, M. Brocco, S. Dapremont and D. Passerieux for invaluable assistance in the preparation of this article, together with J.-M. Besson, A. Dickenson and M. Hamon for helpful comments on the manuscript.
References (1644)
- et al.
Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: a phaseolus vulgaris leucoagglutinin study
Neuroscience
(1995) - et al.
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex
Neuropsychopharmacology
(1999) - et al.
Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
Neurosci. Lett.
(2001) - et al.
A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist
Pain
(2001) - et al.
Brain melanocortin receptors: from cloning to functions
Peptides
(1997) - et al.
Melanocortins and the brain: from effects via receptors to drug targets
Eur. J. Pharmacol.
(2000) - et al.
Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog
Neuropharmacology
(1997) - et al.
Microinjection of arginine vasopressin into the central nucleus of amygdala suppressed nociceptive jaw opening reflex in freely moving rats
Brain Res. Bull.
(2001) - et al.
Antinociception and cardiovascular responses produced by electrical stimulation in the nucleus tractus solitarius, nucleus reticularis ventralis and the caudal medulla, nucleus reticularis ventralis, and the caudal medulla
Pain
(1990) - et al.
Effect of protein kinase C activation on the glycine evoked Cl current in spinal cord neurons
Brain Res.
(2001)
Antinociceptive effect of ketanserin in mice: involvement of supraspinal 5-HT2 receptors in nociceptive transmission
Brain Res.
The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies
Brain Res.
The role of 5-HT3 receptors in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies
Neurosci. Lett.
Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies, in the rat spinal cord: biochemical and immunocytochemical studies
Neuroscience
Evidence for neuropeptideFF (FLFQPQRFamide) in rat dorsal root ganglia
Peptides
Descending projections from the medullary dorsal reticular nucleus make synaptic contacts with spinal cord lamina I cells projecting to that nucleus: an electron microscopic tracer study in the rat
Neuroscience
The medullary dorsal reticular nucleus facilitates acute nociception in the rat
Brain Res. Bull.
Neuropeptide FF in the VTA blocks the analgesic effects of both intra-VTA morphine and exposure to stress
Brain Res.
The role of dopamine in the nucleus accumbens in analgesia
Life Sci.
The effects of cannabinoids on the brain
Prog. Neurobiol.
Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla
Neuroscience
Metabotropic glutamate receptors: electrophysiological properties and role in plasticity
Brain Res. Rev.
Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain
Neurosci. Lett.
Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine
Brain Res.
Dynorphin A increases substance P release from trigeminal primary afferent C-fibers
Eur. J. Pharmacol.
Antinociceptive effects of acute and chronic injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats
Pain
Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat
Brain Res.
Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes
Brain Res.
Cellular distribution of the rat D1B receptor in central nervous system using anti-receptor antisera
Brain Res.
Influence of oxytocin on nociception and morphine antinociception
Neuropeptides
Lack of effect of opioids on neuropathic and idiopathic forms of pain
Pain
Involvement of GABAergic systems in manifestation of pharmacological activity of desipramine
Jpn. J. Pharmacol.
The behavioural importance of dynamically activated descending inhibition from the nucleus reticularis gigantocellularis pars alpha
Pain
Release into ventriculo-cisternal perfusate of β-endorphin- and Met-enkephalin-immunoreactivity: effects of electrical stimulation in the arcuate nucleus and periaqueductal gray of the rat
Brain Res.
Ultrastructural analysis of ventrolateral periaqueductal gray projections to the A7 catecholamine cell group
Neuroscience
The neuropeptideFF analogue, IDME, enhances in vivo met-enkephalin release from the rat spinal cord
Neuropharmacology
Sensitization of pain pathways in the spinal cord: cellular mechanisms
Prog. Neurobiol.
The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat
Eur. J. Pharmacol.
Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats
Brain Res.
Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats
Pain
Effect of intrathecal administration of serotonin in chronic pain models in rats
Eur. J. Pharmacol.
In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia
Eur. J. Pharmacol.
A review of central 5-HT receptors and their function
Neuropharmacology
Role of endogenous cannabinoid system in the formalin test of persistent pain in the rat
Eur. J. Pharmacol.
The nuclei of origin of brainstem serotonergic projections to the rodent spinal trigeminal nucleus
Neurosci. Lett.
The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin
Brain Res.
The nuclei of origin of brainstem enkephalin and cholecystokinin projections to the spinal trigeminal nucleus of the rat
Neuroscience
Effects of intrathecal ACTH on opiate analgesia in the rat
Brain Res.
Differential effects of SKF 38393 and LY 141865 on nociception and morphine analgesia
Life Sci.
The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia
Pain
Cited by (2473)
Ayahuasca and its major component harmine promote antinociceptive effects in mouse models of acute and chronic pain
2024, Journal of EthnopharmacologyAssociation between myofascial trigger point therapy and conditioned pain modulation
2024, Journal of Bodywork and Movement TherapiesNovel aspects of signal processing in lamina I
2024, Neuropharmacology